Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPP Study: Carbetocin versus Oxytocin for Prevention of Postpartum Haemorrhage
PACTR202507509436209Not yet recruiting
- Sponsor
- University of Ilorin
- Start
- Sep 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of carbetocin and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by University of Ilorin. Primary endpoint: Incidence of postpartum haemorrhage. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202507509436209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507509436209.